Quality Control News and Research

RSS

Crothall partners with 3M to implement effective infection control

Crothall Healthcare, a premier provider of support services to healthcare clients, announced its Preferred Partnership arrangement with 3M to kick-off its powerfully enhanced approach to infection control.

29 Dec 2010

Exiqon announces introduction of GLP compliant services for miRNA biomarker screening

Exiqon A/S, a leading provider of technologies for biomarker detection, today announced the introduction of GLP compliant services for miRNA biomarker screening and diagnostic assay development for clinical trials.

27 Dec 2010

Scientist discovers molecular switch controlling synthesis of ribosomes

A scientist from the Florida campus of The Scripps Research Institute has discovered a molecular switch that controls the synthesis of ribosomes. Ribosomes are the large machineries inside all living cells that produce proteins, the basic working units of any cell. These new findings offer a novel target for potential treatments for a range of diseases, including cancer.

23 Dec 2010

Mesa Labs announces acquisition of Apex's biological indicators business

Mesa Laboratories, Inc., a Lakewood, Colorado based manufacturer of electronic instruments and disposables today announced the acquisition of the biological indicators business of Apex Laboratories, Inc., a North Carolina based company. The acquisition of the Apex business is expected to be immediately accretive to Mesa's earnings per share.

22 Dec 2010

NAFC forms council to establish independent quality standards for incontinence products

The National Association For Continence (NAFC) is heading a newly formed council with the objective of establishing national, independent quality standards for disposable adult absorbent products provided by states to Medicaid waiver recipients cared for in their private homes rather than as residents of a state-funded nursing home.

20 Dec 2010

MOCON board declares quarterly cash dividend of $0.095 per share

MOCON, Inc. announced today that on December 16, 2010, its Board of Directors declared a quarterly cash dividend of nine and one-half cents ($0.095) per share, payable on February 18, 2011, to shareholders of record on February 4, 2011.

17 Dec 2010

Mayo clinic creates new computerized radiation tracking system

Mayo Clinic is initiating a new imaging exam tracking system that, among other things, enables a comprehensive view of a patient's radiation exposures over time.

13 Dec 2010

FDA grants Neoprobe Type B pre-IND meeting for RIGS technology BLA

Neoprobe Corporation, a diversified developer of innovative oncology surgical and diagnostic products, today announced that it has requested and been granted a Type B pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding its RIGS® technology Biologic License Application (BLA). The pre-IND meeting request is another step in Neoprobe's efforts to develop and commercialize the RIGS technology designed to enhance the surgical treatment of patients with solid tumor cancers.

10 Dec 2010

MyHospital website goes live

The public will have access to nationally-consistent performance data for almost 1,000 Australian hospitals online for the first time at the federal government’s MyHospitals website. The website includes information on 922 public and private hospitals around the country and is live at 11am (AEDT) on Friday.

9 Dec 2010

e-cigarettes spark debate in U.S.

Electronic cigarettes have been seen as a tobacco product but not as drugs. The US Food and Drug Administration had appealed to the court to treat these cigarettes as drugs but the court says this is an oversight. The FDA cited five e-cigarette distributors for poor manufacturing practices and falsely claiming that the products help people stop smoking.

8 Dec 2010

Financial Times contrasts 'bottom up' and 'top down' approaches to developing country drugs

The Financial Times contrasts the model of drug development for developing countries being used by non-profit groups like the Meningitis Vaccine Project (MVP), which recently rolled out the MenAfriVac, to that of some pharmaceutical companies.

8 Dec 2010

Concentrated nicotine in E-cigarattes poses unknown risks to consumers

What do some pesticides and "electronic cigarettes" have in common? According to a new report published in the American Journal of Public Health, the answer is unregulated concentrations of nicotine that may pose unknown risks to consumers who are exposed to them.

8 Dec 2010

Electronic cigarettes are potentially harmful, researchers say

Electronic cigarettes (or e-cigarettes), also called "electronic nicotine delivery systems," are increasingly used worldwide even though only sparse information is available on their health effects. In the United States, e-cigarettes are readily available in shopping malls in most states and on the Internet.

4 Dec 2010

Prostate cancer imaging shows real-time tumor metabolism

A UCSF research collaboration with GE Healthcare has produced the first results in humans of a new technology that promises to rapidly assess the presence and aggressiveness of prostate tumors in real time, by imaging the tumor's metabolism.

3 Dec 2010

Expert panel at RSNA meeting to discuss medical imaging technique

An expert panel convened today at the annual meeting of the Radiological Society of North America (RSNA) to discuss medical imaging appropriateness, ionizing radiation from imaging procedures and efforts under way to curb overutilization, decrease radiation dose and educate patients on the risks and benefits of medical imaging.

2 Dec 2010

CRN issues statement on passage of FDA Food Safety Modernization Act

"CRN is pleased that the Senate today passed S. 510, FDA Food Safety Modernization Act (FDAFSMA). CRN and its member companies support this bill because of the added enforcement tools it would provide to FDA and the extra protections it would provide for consumers.

1 Dec 2010

Jiangsu Yanshen found liable for producing and selling inferior quality products

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China, today announced that Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen"), in which Simcere holds a 52.5% controlling stake, has been found liable for producing and selling inferior quality products by the People's Court of Tianning District, Changzhou City and was sentenced to a fine of RMB4.6 million.

30 Nov 2010

$Bruker’s AcuityXR with ContourGT optical surface profilers break diffraction limit$

Bruker’s AcuityXR with ContourGT optical surface profilers break diffraction limit

Bruker Corporation announced today at the Materials Research Society (MRS) Fall 2010 Meeting the AcuityXR™, a novel optical surface profiler mode that combines unique, patent-pending Bruker hardware and software technology to enable select ContourGT™ non-contact, 3D optical surface profilers to break the optical diffraction limit and deliver lateral resolutions that were previously considered impossible to achieve.

From Bruker Nano Surfaces and Metrology 30 Nov 2010

Researchers conduct real-time metabolic imaging in human patient with prostate tumor

30 Nov 2010

University of Adelaide researcher leads collaboration for universal flu vaccine

A University of Adelaide researcher is leading a collaboration between Australia and Indonesia on the production of a universal flu vaccine. The frequent arising of new influenza strains represents the greatest challenge to health authorities as it renders currently available vaccines ineffective, says Dr Mohammed Alsharifi, the Head of the Vaccine Research Group at the School of Molecular and Biomedical Science, University of Adelaide.

30 Nov 2010